Table 2.
Data on patients with self-resolving or false-positive FDG-PET results
| Pt. no. | Age, yr/sex | Primary cancer | Status | SUV | Size, cm | Time to repeat imaging, mo |
|---|---|---|---|---|---|---|
| 1 | 83/M | Lymphoma | Relapse after chemotherapy | 4.2 | 1.1 | 6* |
| 2 | 60/F | Lymphoma | Partial response after chemotherapy | 9.1 | 2.4 | 6† |
| 3 | 50/F | Sarcoma | Disease-free after surgery | 4.5 | 1.0 | 1* |
| 4 | 75/F | Lung cancer | Staging | 4.6 | 1.1 | 10† |
| 5 | 75/M | Lymphoma | Complete remission after chemotherapy/stem cell transplant | 4.5 | 1.0 | 6† |
F = female; FDG-PET = fluorodeoxyglucose positron emission tomography; M = male; SUV = standardized uptake value.
*
Ultrasonography.
†
Positron emission tomography.